Dr. Lynne Abruzzo is the new chair of the MCG’s Department of Pathology – Jagwire

Dr. Lynne Abruzzo, former co-director of the James Cancer Center Cytogenetics Laboratory at Wexner Medical Center at Ohio State University, is the new chair of the Department of Pathology to Georgia Medical College at Augusta University.

Abruzzo, who joins MCG on July 1, will help support and grow research programs in the department and lead efforts to create new collaborative research programs across the medical school that will ultimately lead to better treatments for patients. .

She studies cytogenetics, which is the analysis of chromosomal changes that may be related to genetic diseases or cancer. His research focuses on the genetics and pathogenesis of chronic lymphocytic leukemia, the most common leukemia in adults, and other low-grade B-cell leukemias and lymphomas. She is working to identify biomarkers that measure disease progression in CLL patients and how these markers can help doctors better manage and treat their patients.

She was Co-Director of the Cytogenetics Laboratory at the James Cancer Center since 2014. A professor in the Division of Cytogenetics in the Department of Pathology at OSU Wexner Medical Center in Columbus, she also served as the specialty program director for Clinical Molecular Genetics and Clinical Cytogenetics Laboratory Fellowship Program at Wexner Medical Center and Children’s National Hospital from 2015-2021.

Abruzzo originally trained in hematopathology, the study of diseases of the cells that make up the blood, specializing in the diagnosis of lymphomas and translational research. After working in the field for nearly two decades, at places like the National Institutes of Health and the MD Anderson Cancer Center, in 2004 she completed further training in clinical cytogenetics at Baylor College of Medicine in Houston. At the end of her first year of training, she returned to MD Anderson to lead the clinical cytogenetics laboratory, a position she held until joining OSU in 2013. She completed her fellowship in 2006.

“Dr. Abruzzo is an accomplished physician/scientist with a long track record in National Institutes of Health funding,” says Dr. David HesseDean of MCG.

“His research, focusing on the relationship between chromosomal alterations and genetic diseases, such as CLL, is particularly impactful because CLL diagnoses account for more than 25% of new leukemia cases each year. I am thrilled to see her establishing vibrant research collaborations with colleagues on campus, especially with physicians and scientists at the Georgia Cancer Center, which will ultimately result in better personalized treatments for people with this disease. terrible and incurable. I am also extremely grateful to the interim president, Dr. Sravan Kavouri for his steadfast leadership of the department over the past year.

Abruzzo is a member of the Board of Scientific Advisors for the National Cancer Institute and a former member of the Board of Scientific Advisors for the National Heart, Lung, and Blood Institute. She served as chair of the Association for Molecular Pathology’s hematopathology subdivision and its program committee.

From 2006 to 2018, she served on the editorial board of Human pathology. She has authored and co-authored over 160 peer-reviewed journal articles and seven book chapters.

She received her medical degree from the Pritzker School of Medicine and a doctorate in pathology, both from the University of Chicago. In addition to her clinical cytogenetics fellowship at Baylor, she completed a clinical residency in anatomical and clinical pathology at the University of Michigan; a fellowship in clinical hematopathology at the National Cancer Institute; and a fellowship at the National Institute of Diabetes, Digestive and Kidney Diseases.


To like
Ha ha


Leave a Comment